Sanofi SA (SNY)
50.00
+0.78
(+1.57%)
USD |
NASDAQ |
May 01, 16:00
50.00
0.00 (0.00%)
After-Hours: 17:50
Sanofi Revenue (TTM): 50.69B for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 50.69B |
| December 31, 2023 | 50.28B |
| September 30, 2023 | 48.85B |
| June 30, 2023 | 48.26B |
| March 31, 2023 | 48.06B |
| December 31, 2022 | 47.67B |
| September 30, 2022 | 47.87B |
| June 30, 2022 | 47.40B |
| March 31, 2022 | 46.86B |
| December 31, 2021 | 46.29B |
| September 30, 2021 | 43.67B |
| June 30, 2021 | 41.18B |
| March 31, 2021 | 41.37B |
| June 30, 2020 | 41.70B |
| March 31, 2020 | 42.49B |
| December 31, 2019 | 42.11B |
| September 30, 2019 | 41.66B |
| June 30, 2019 | 41.96B |
| March 31, 2019 | 41.99B |
| December 31, 2018 | 42.08B |
| September 30, 2018 | 42.04B |
| June 30, 2018 | 41.75B |
| March 31, 2018 | 41.45B |
| December 31, 2017 | 40.95B |
| September 30, 2017 | 40.24B |
| Date | Value |
|---|---|
| June 30, 2017 | 39.57B |
| March 31, 2017 | 39.13B |
| December 31, 2016 | 38.39B |
| September 30, 2016 | 35.98B |
| June 30, 2016 | 36.36B |
| March 31, 2016 | 36.66B |
| December 31, 2015 | 37.19B |
| September 30, 2015 | 38.53B |
| June 30, 2015 | 39.53B |
| March 31, 2015 | 41.02B |
| December 31, 2014 | 42.60B |
| September 30, 2014 | 42.67B |
| June 30, 2014 | 42.21B |
| March 31, 2014 | 41.60B |
| December 31, 2013 | 41.51B |
| September 30, 2013 | 43.86B |
| June 30, 2013 | 44.12B |
| March 31, 2013 | 45.26B |
| December 31, 2012 | 46.21B |
| September 30, 2012 | 47.00B |
| June 30, 2012 | 48.41B |
| March 31, 2012 | 49.34B |
| December 31, 2011 | 48.83B |
| September 30, 2011 | 50.13B |
| June 30, 2011 | 47.83B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
41.18B
Minimum
Jun 2021
50.69B
Maximum
Mar 2024
45.47B
Average
46.57B
Median
Revenue (TTM) Benchmarks
| AstraZeneca PLC | 47.61B |
| GSK PLC | 37.75B |
| Novo Nordisk A/S | 33.71B |
| Regeneron Pharmaceuticals Inc | 13.12B |
| Biophytis SA | -- |